Aimz Investment Advisors, LLC Amgen Inc Transaction History

Aimz Investment Advisors, LLC

  • $276 Million
  • Q2 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 13,539 shares of AMGN stock, worth $4.33 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
13,539
Previous 13,692 1.12%
Holding current value
$4.33 Million
Previous $3.89 Million 8.68%
% of portfolio
1.53%
Previous 1.47%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$262.75 - $319.31 $40,200 - $48,854
-153 Reduced 1.12%
13,539 $4.23 Million
Q1 2024

May 10, 2024
SELL
$268.87 - $324.56 $113,732 - $137,288
-423 Reduced 3.0%
13,692 $3.89 Million
Q4 2023

Jan 26, 2024
SELL
$255.7 - $288.46 $39,889 - $44,999
-156 Reduced 1.09%
14,115 $4.07 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $21,646 - $26,874
-99 Reduced 0.69%
14,271 $3.84 Million
Q2 2023

Aug 08, 2023
BUY
$214.27 - $253.37 $428 - $506
2 Added 0.01%
14,370 $3.19 Million
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $16,482 - $20,089
-73 Reduced 0.51%
14,368 $3.47 Million
Q4 2022

Feb 10, 2023
SELL
$229.03 - $291.01 $96,879 - $123,097
-423 Reduced 2.85%
14,441 $3.79 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $5,387 - $6,075
-24 Reduced 0.16%
14,864 $3.35 Million
Q2 2022

Aug 02, 2022
SELL
$230.71 - $256.74 $15,688 - $17,458
-68 Reduced 0.45%
14,888 $3.62 Million
Q1 2022

May 06, 2022
SELL
$219.27 - $242.57 $87,269 - $96,542
-398 Reduced 2.59%
14,956 $3.62 Million
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $79,750 - $91,267
401 Added 2.68%
15,354 $3.45 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $5,519 - $6,466
-26 Reduced 0.17%
14,953 $3.18 Million
Q2 2021

Aug 05, 2021
SELL
$233.58 - $259.14 $9,810 - $10,883
-42 Reduced 0.28%
14,979 $3.65 Million
Q1 2021

Apr 28, 2021
SELL
$221.91 - $258.6 $35,061 - $40,858
-158 Reduced 1.04%
15,021 $3.74 Million
Q4 2020

Feb 08, 2021
BUY
$216.38 - $257.67 $216 - $257
1 Added 0.01%
15,179 $3.49 Million
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $43,175 - $48,014
-184 Reduced 1.2%
15,178 $3.86 Million
Q2 2020

Aug 07, 2020
SELL
$197.81 - $242.74 $14,440 - $17,720
-73 Reduced 0.47%
15,362 $3.62 Million
Q1 2020

May 12, 2020
SELL
$182.24 - $241.7 $31,709 - $42,055
-174 Reduced 1.11%
15,435 $3.13 Million
Q4 2019

Feb 13, 2020
SELL
$189.21 - $243.2 $66,034 - $84,876
-349 Reduced 2.19%
15,609 $3.76 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $64,768 - $77,606
-372 Reduced 2.28%
15,958 $3.09 Million
Q2 2019

Aug 14, 2019
BUY
$166.7 - $195.41 $166 - $195
1 Added 0.01%
16,330 $3.01 Million
Q1 2019

May 15, 2019
BUY
$180.87 - $203.88 $361 - $407
2 Added 0.01%
16,329 $3.1 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $111,856 - $130,572
-627 Reduced 3.7%
16,327 $3.18 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $148,046 - $166,903
-799 Reduced 4.5%
16,954 $3.51 Million
Q2 2018

Aug 14, 2018
SELL
$166.05 - $186.51 $16,438 - $18,464
-99 Reduced 0.55%
17,753 $3.28 Million
Q1 2018

May 01, 2018
SELL
$169.43 - $198.0 $33,547 - $39,204
-198 Reduced 1.1%
17,852 $3.04 Million
Q4 2017

Feb 14, 2018
SELL
$168.79 - $188.59 $12,321 - $13,767
-73 Reduced 0.4%
18,050 $3.14 Million
Q3 2017

Nov 01, 2017
BUY
$167.29 - $191.0 $167 - $191
1 Added 0.01%
18,123 $3.38 Million
Q2 2017

Aug 15, 2017
BUY
N/A
18,122
18,122 $3.12 Million

Others Institutions Holding AMGN

# of Institutions
3,080
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email